What is the level of liabilities of Neurogene this year?
Neurogene has a debt balance of 36.55 M USD this year.
Neurogene Liabilities 2024
Neurogene Liabilities
36.55 M USD
Ticker
NGNE
ISIN
US64135M1053
In 2024, Neurogene's total liabilities amounted to 36.55 M USD, a 69.21% difference from the 21.6 M USD total liabilities in the previous year.
Neurogene Aktienanalyse
What does Neurogene do?
Neurogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Neurogene's Liabilities
Neurogene's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Neurogene's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Neurogene's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Neurogene's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Neurogene’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Neurogene stock
What were the liabilities of Neurogene compared to the previous year?
The liabilities of Neurogene have increased by 69.21% increased compared to the previous year.
What are the consequences of high debt for investors of Neurogene?
High liabilities can pose a risk for investors of Neurogene, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Neurogene?
Low liabilities mean that Neurogene has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Neurogene affect the company?
An increase in liabilities of Neurogene can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Neurogene affect the company?
A decrease in the liabilities of Neurogene can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Neurogene?
Some factors that can influence the liabilities of Neurogene include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Neurogene so important for investors?
The liabilities of Neurogene are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Neurogene take to modify the liabilities?
To change its liabilities, Neurogene can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Neurogene pay?
Over the past 12 months, Neurogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Neurogene is expected to pay a dividend of 0 USD.
What is the dividend yield of Neurogene?
The current dividend yield of Neurogene is .
When does Neurogene pay dividends?
Neurogene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Neurogene?
Neurogene paid dividends every year for the past 0 years.
What is the dividend of Neurogene?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Neurogene located?
Neurogene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Neurogene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Neurogene from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.
When did Neurogene pay the last dividend?
The last dividend was paid out on 11/16/2024.
What was the dividend of Neurogene in the year 2023?
In the year 2023, Neurogene distributed 0 USD as dividends.
In which currency does Neurogene pay out the dividend?
The dividends of Neurogene are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Neurogene
Our stock analysis for Neurogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neurogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.